ASAM Drug Testing Pocket Guide

Drug Testing Pocket Guide

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link:

Contents of this Issue


Page 1 of 35

2 Key Points Recommendations in this document are not intended to substitute for independent clinical judgement based on the particular facts and circumstances presented by individual patients. Î The dramatic proliferation of potentially addictive drugs is one of the most challenging problems facing drug testing today*. Î No universal standard exists in clinical drug testing for addiction identification, diagnosis, treatment, medication monitoring, or recovery. Î The purpose of this Drug Testing pocket guide is to provide guidance on the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction. Î It is intended for use by providers who utilize drug testing in clinical settings and healthcare administrators in residential, outpatient, and other settings. Î Inappropriate use of drug testing is both wasteful and unethical. Examples include: • The routine use of large, arbitrary test panels. • Unnecessarily frequent drug testing without consideration for the drug's window of detection. • The confirmation and quantification of all presumptive positive and negative test results. Î Unlike clinical practice guidelines, which typically focus on disease- specific treatment recommendations, this pocket guide focuses on recommendations for where, when, and how often a drug test should be performed. Î This ASAM Drug Testing pocket guide is intended to aid clinicians in their clinical decision-making and patient management. It strives to identify and define clinical decision-making junctures that meet the needs of most patients in most circumstances. Clinical decision- making should involve consideration of the quality and availability of expertise and services in the community wherein care is provided. In circumstances in which the Drug Testing pocket guide is being used as the basis for regulatory or payer decisions, improvement in quality of care should be the goal. * ASAM Drug Testing : A White Paper of the American Society of Addiction Medicine. Chevy Chase, MD: American Society of Addiciton Medicine; 2013. Available at: http://www.asam. org/docs/default-source/public-policy-statements/drug-testing-a-white-paper-by-asam.pdf

Articles in this issue

Archives of this issue

view archives of ASAM Drug Testing Pocket Guide - Drug Testing Pocket Guide